Argipressin's Influence on Blood Loss During Hepatic Resection

Clinical trial NCT05293041 · COMPLETED

Trial details

NCT number: NCT05293041
Sponsor: Kristina Svennerholm
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Colon Cancer Liver Metastasis Inflammatory Response Vasopressin Causing Adverse Effects in Therapeutic Use

Start date: 2022-03-27
Primary completion: 2024-12-06
Enrollment: 248

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.